National Healthcare NHC
Valuation
Multiples measured against the stock's own five-year history
Above its usual level · 73rd percentile, 5-year average 22.8x
#2094 of 2993 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 92nd percentile, 5-year average 1.7x
#3683 of 5330 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 92nd percentile, 5-year average 1.3x
#2587 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.90 | – | 1.66 | 92% (pricier than usual) | #3683 of 5330 (1 = cheapest) |
| PE | 28.76 | – | 22.82 | 73% (pricier than usual) | #2094 of 2993 (1 = cheapest) |
| PS | 2.06 | – | 1.27 | 92% (pricier than usual) | #2587 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on NHC.
Sign in to join the discussion.